Details for Patent: 10,293,047

Which drugs does patent 10,293,047 protect, and when does it expire?

Patent 10,293,047 protects FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE and is included in one NDA.

This patent has four patent family members in four countries.

Summary for Patent: 10,293,047

Title:	Fluorescein and benoxinate compositions
Abstract:	Compositions comprising a fluorescein component and benoxinate component and the corresponding uses of these compositions are described herein. These compositions have improved storage life and the fluorescein component and/or benoxinate component minimally degrade after 12 to 18 months of storage.
Inventor(s):	Patrick H. Witham, Sailaja Machiraju
Assignee:	Paragon Bioteck Inc
Application Number:	US15/814,186
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 10,293,047

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bausch Lomb Ireland	FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE	benoxinate hydrochloride; fluorescein sodium	SOLUTION/DROPS;OPHTHALMIC	211039-001	Mar 9, 2020		RX	Yes	Yes	10,293,047		Y			OCULAR EXAMINATION, INTRAOCULAR PRESSURE MEASUREMENT, OR REMOVAL OF FOREIGN BODIES OR SUTURES, IN ADULT AND PEDIATRIC PATIENTS REQUIRING A DISCLOSING AGENT IN COMBINATION WITH A TOPICAL OPHTHALMIC ANESTHETIC

International Family Members for US Patent 10,293,047

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	3082603
China	111565761
European Patent Office	3710069
World Intellectual Property Organization (WIPO)	2019099739